Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in AIDS Res Hum Retroviruses

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    April 2018
  1. ERLANDSON KM, Streifel A, Novin A, Hawkins K, et al
    Low Rates of Vaccination for Herpes Zoster in Older People Living with HIV.
    AIDS Res Hum Retroviruses. 2018 Apr 17. doi: 10.1089/AID.2017.0315.
    PubMed     Text format     Abstract available


    January 2018
  2. HUANG Y, Zhang L, Jolliffe D, Sanchez B, et al
    Post-vaccination C-Reactive Protein (CRP) and C5/gp41732-744 Antibody Level Fold-changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x.
    AIDS Res Hum Retroviruses. 2018 Jan 3. doi: 10.1089/AID.2017.0179.
    PubMed     Text format     Abstract available


    November 2017
  3. SANDERS-BEER BE, Voronin Y, McDonald D, Singh A, et al
    HARNESSING NOVEL IMAGING APPROACHES TO GUIDE HIV PREVENTION AND CURE DISCOVERIES - A NATIONAL INSTITUTES OF HEALTH AND GLOBAL HIV VACCINE ENTERPRISE 2017 MEETING REPORT.
    AIDS Res Hum Retroviruses. 2017 Nov 16. doi: 10.1089/AID.2017.0216.
    PubMed     Text format     Abstract available


    October 2017
  4. KARLSSON I, Borggren M, Jensen SS, Heyndrickx L, et al
    Immunization with clinical HIV-1 Env proteins induces broad antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies in a rabbit vaccination model.
    AIDS Res Hum Retroviruses. 2017 Oct 6. doi: 10.1089/AID.2017.0140.
    PubMed     Text format     Abstract available


  5. VIEGAS EO, Tembe N, Nilsson C, Meggi B, et al
    Intradermal HIV-1 DNA immunization using needle-free Zetajet<sup>TM</sup> injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial.
    AIDS Res Hum Retroviruses. 2017 Oct 2. doi: 10.1089/AID.2017.0121.
    PubMed     Text format     Abstract available


    September 2017
  6. FLEURY HJ, Tumiotto C, Bellecave P, Recordon-Pinson P, et al
    Therapeutic vaccine against HIV, viral variability, CTL epitopes and genetics of patients.
    AIDS Res Hum Retroviruses. 2017.
    PubMed     Text format     Abstract available


    May 2017
  7. MARTINS MA, Tully DC, Shin YC, Gonzalez-Nieto L, et al
    Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque.
    AIDS Res Hum Retroviruses. 2017 May 13. doi: 10.1089/AID.2017.0046.
    PubMed     Text format     Abstract available


    March 2017
  8. MEYERHOFF RR, Scearce RM, Ogburn DF, Lockwood B, et al
    HIV-1 consensus envelope-induced broadly binding antibodies.
    AIDS Res Hum Retroviruses. 2017 Mar 17. doi: 10.1089/AID.2016.0294.
    PubMed     Text format     Abstract available


    December 2016
  9. JOACHIM A, Munseri PJ, Nilsson C, Bakari M, et al
    Three-year durability of immune responses induced by HIV-DNA and HIV-modified vaccinia virus Ankara and effect of a late HIV-MVA boost in Tanzanian volunteers.
    AIDS Res Hum Retroviruses. 2016 Dec 27. doi: 10.1089/AID.2016.0251.
    PubMed     Text format     Abstract available


  10. KARNASUTA C, Akapirat S, Madnote S, Savadsuk H, et al
    Comparison of Antibody Responses Induced by RV144, VAX003 and VAX004 Vaccination Regimens.
    AIDS Res Hum Retroviruses. 2016 Dec 22. doi: 10.1089/AID.2016.0204.
    PubMed     Text format     Abstract available


  11. KARPENKO LI, Lebedev LR, Bazhan SI, Korneev DV, et al
    Visualization of CombiHIVvac Vaccine Particles Using Electron Microscopy.
    AIDS Res Hum Retroviruses. 2016.
    PubMed     Text format    


    November 2016
  12. SEALY R, Hurwitz JL
    Parallel analyses of systemic and local vaccinations with envelope formulated in adjuvant for induction of HIV-specific antibodies in the vaginal mucosa.
    AIDS Res Hum Retroviruses. 2016.
    PubMed     Text format     Abstract available


    September 2016
  13. KEEFER M, Zheng B, Rosenberg AF, Kobie JJ, et al
    Increased steady-state memory B cell subsets among high-risk participants in an HIV vaccine trial.
    AIDS Res Hum Retroviruses. 2016.
    PubMed     Text format     Abstract available


    June 2016
  14. SAFRIT JT, Tomaras GD, Hanke T, deCamp AC, et al
    The Landscape of Targeted Immune Responses in the HIV-1 Vaccine Field.
    AIDS Res Hum Retroviruses. 2016.
    PubMed     Text format     Abstract available


    December 2015
  15. BORGREN M, Jensen SS, Heyndrickx L, Palm A, et al
    Neutralizing antibody response and antibody-dependent cellular cytotoxicity in HIV-1 infected individuals from Guinea-Bissau and Denmark.
    AIDS Res Hum Retroviruses. 2015.
    PubMed     Text format     Abstract available


    November 2015
  16. TSACHOURIDOU O, Skoura L, Zebekakis P, Margariti A, et al
    Memory B Cell Divergences upon Immunization Against Streptococcus pneumoniae in HIV-1-Infected Adults.
    AIDS Res Hum Retroviruses. 2015.
    PubMed     Text format    


    October 2015
  17. HOPE T, Marrazzo JM
    A Shot in the Arm for HIV Prevention? Recent successes & critical thresholds.
    AIDS Res Hum Retroviruses. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: